Home > Insider Trading > Filing (0001225208-10-019538)

Filing Details

Accession Number:: 0001225208-10-019538
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-08-19 13:00:00
Reporting Period:: 2010-08-17

Filing Date:: 2010-08-19
Accepted Time:: 2010-08-19 16:10:58
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885725	Boston Scientific Corp	BSX	Surgical & Medical Instruments & Apparatus (3841)	042695240

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
901430	E John Abele	One Boston Scientific Place Natick MA 01760-1537		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-08-17	4,200	$5.52	50,000	No	4	S	Indirect	By LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By LLC

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Forward Sale Contract (obligation to sell)	Acquisiton	2010-08-17	490,000	$0.00	490,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
490,000	2012-08-17	2012-08-17	No	4	J	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	13,112,718	Direct
Common Stock	400,000	Indirect	By Spouse
Common Stock	351,098	Indirect	By Trust

Footnotes

Sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $5.84 to $5.43. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
Common stock held by a limited liability company of which reporting person holds 100% membership interest.
Common stock held by the reporting person's wife. The reporting person disclaims beneficial ownership of these shares.
Common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. The reporting person disclaims beneficial ownership of these shares.
On March 1, 2010, the reporting person entered into a Rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. Under the contract reported on this form, the reporting person will deliver to the bank up to 490,000 shares of the Issuer's common stock depending on market prices at maturity on August 17, 2012. If the market price per share at maturity is equal to or less than the floor price of $5.4822 per share, the reporting person will deliver 490,000 shares to the bank. If the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. In exchange, the bank is obligated to pay $1,813,237.65 to the reporting person two business days after the date of the contract. At the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
The reporting person pledged 490,000 shares of the Issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.